US FDA gives guidance on risk presentation in DTC ads
28 May 2009
Sue Sutter
Pharmaceutical manufacturers should present a comparable quantity of benefit and risk information in product advertisements and avoid using distracting graphics that detract from a reasonable consumer's comprehension of the risk presentation, the US
FDA said in new draft guidelines.
The guidelines...
Please Login to read the full article.
28 May 2009
Sue Sutter
The guidelines...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Obama seeks to secure global supply chain; reveals new plan
- EC cross-border prescribing measures should help avoid product confusion
- Banning DTC Rx ads will not lower drug prices, says US Budget Office
- US FDA not yet ready to 'share' social media guidelines
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
